news

With the start of the new year, one of the little noticed but potentially harmful features of Obamacare has now gone into effect. It is the tax on medical device manufacturers. The new tax of 2.3 percent is placed on the revenues of companies that produce medical devices such as heart valves, insulin pumps and hundreds of thousands of carefully engineered and regularly improved… Read more »

During a time when our nation’s economy struggles to stabilize and manufacturing jobs continue to diminish there has been one industry within the manufacturing sector that has ascended as a global leader – America’s medical device industry. This industry, described as an American success story, has brought us lifesaving technologies such as pacemakers, CT scanners, artificial joints,… Read more »

Today, Congressman Bob Latta (R-Bowling Green) toured the Cleveland Clinic to see firsthand how his repackaging language related to drug shortages helps patients receive access to quality care in a timely manner. Latta authored language, which was included in the Food and Drug Administration Safety and Innovation Act and signed into law this July, to help ease drug shortages in the… Read more »

Congressman Bob Latta (R-Bowling Green) voted to repeal the Patient Protection and Affordable Care Act (PPACA), which passed on the House Floor this afternoon, and issued the following statement: “A massive government takeover of our health care system that costs too much and raises taxes on American families and small businesses is not the right answer.  Of the 21 new tax increases… Read more »

Congressman Bob Latta (R-Bowling Green) issued the following statement following the ruling made today by the Supreme Court of the United States (SCOTUS) regarding the Patient Protection and Affordable Care Act (PPACA): “I am extremely disappointed with the Supreme Court’s ruling this morning.  Since the passage of PPACA, the American people have found that costs will go up not… Read more »

Today, Congressman Bob Latta (R-Bowling Green) issued the following statement after the House of Representatives agreed to amendments to S. 3187, the Food and Drug Administration Safety and Innovation Act.  The House and Senate have been working on bipartisan legislation to reauthorize the user fee programs for prescription drugs and medical devices, as well as establish user fee… Read more »

Today, Congressman Bob Latta (R-Bowling Green) issued the following statement after voting in support of the Health Care Cost Reduction Act of 2012 (H.R. 436).  The Democrat health care law, Obamacare, contains many items that are harmful to both patients and businesses.  H.R. 436 repeals important provisions from Obamacare by combining four bipartisan bills to reduce health… Read more »

Today, Congressman Bob Latta (R-Bowling Green) issued the following statement after he voted for the Food and Drug Administration Reform Act, H.R. 5651.  “This important legislation will reauthorize user fee programs for prescription drugs and medical devices, establish user fee programs for generic drugs and biosimilars, as well as reform Food and Drug Administration (FDA)… Read more »

This week, the House Energy and Commerce Subcommittee on Health passed H.R. 1215, a bill introduced by Congressman Bob Latta (R-Bowling Green) that eliminates mandatory appropriations amounting to $375 million from the Patient Protection and Affordable Care Act (PPACA), Obamacare.  The bill relates to a provision of Obamacare that established grants for personal responsibility… Read more »

Congressman Bob Latta (R-Bowling Green) today issued the following statement on the one year anniversary of the passage of Obamacare: “Against the wishes of the American people the Patient Protection and Affordable Care Act, otherwise known as Obamacare, was passed into law a year ago today.  “With promises of providing more jobs and being more widely affordable and available, it… Read more »